Abiopharma

🔍 FELDMAN FREDRIC J (Director)

Company: Capstone Holding Corp. (CAPS)

Report Date: 2026-03-30

Detailed Transactions and Holdings:

• Acquired 95,000 shares of Common Stock (Direct)
  Date: 2026-03-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 95,000.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 105,124 shares of Common Stock (Direct)
  Date: 2026-08-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 200,124.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: THE REPORTED SHARES ARE UNVESTED RESTRICTED STOCK AND MAY NOT BE SOLD, TRANSFERRED OR PLEDGED. Including 95,000 and 105,124 shares of common stock granted to the Reporting Person on March 30, 2026 and August 7, 2026, respectively, as restricted stock awards, for no consideration, under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The restricted stock awards will vest in full only upon the Reporting Person's Separation Date, as defined in the Reporting Person's Master Restricted Stock Agreement.